Estriol and Cognition in Multiple Sclerosis | Clinical Research Studies Listing

Recruiting

18 years - 55 years

Female

Phase 2

1 Location

Brief description of study

The purpose of this study is to determine whether the combination of treatment with available MS therpies and estriol has an effect on cognitive function and disease activity and outcomes.

Detailed description of study

Eligible participants include women with all forms of Multiple Sclerosis on a stable dose of FDA approved MS therapy for 90 days or more. Patients may be off MS therapy, but also for 90 days or more and medically stable. Participants must be able to walk 330 feet without rest (unilateral assistance, such as a cane is allowed). Males are not eligible to participate.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Multiple sclerosis,Chronic Progressive Multiple Sclerosis,RRMS,Relapsing-Remitting Multiple Sclerosis,SPMS,PPMS
Age: 18 years - 55 years
Gender: Female

Updated on 19 Feb 2024. Study ID: 817675

Find a site

Your Information has been sent successfully.

Message sent successfully.

We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.

If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.

Send a message

Enter your contact details to connect with study team

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).